Affiliation:
1. Philipps-University Marburg
2. Technische Hochschule Mittelhessen
3. Schön Clinic Berchtesgadener Land Specialist Centre for Pneumology and Pneumological Rehabilitation Berchtesgaden-Schönau
Abstract
Abstract
Introduction
Clinical symptoms of Diffuse Parenchymal Lung Disease (DPLD) are dyspnoea and dry cough. On auscultation, crackles can be detected at an early stage. The aim of this study was to analyse whether the extent of abnormal breath sounds (crackles, wheezes and coughs) provides an indication of the disease severity and aetiology.
Methodology
In 25 patients with DPLD, an in- hospital overnight recording of physiological and abnormal breath sounds was performed with the LEOSound® monitor. The severity of pulmonary fibrosis was assessed by body plethysmography and GAP score. The perceived breathlessness was assessed by King's Brief Interstitial Lung Disease (K-Bild) questionnaire.
Results
In 16 out of 25 patients, all data were completed in good quality for analysis. Five patients were women (31.3%). The patients’ mean age was 65.8 ± 7.3 years, the mean BMI 28.0 ± 2.4 kg/m2. One patient met GAP I criteria, eight patients GAP II and seven patients met GAP III criteria. The findings of eight patients with idiopathic pulmonary fibrosis (IPF) were compared with those of eight patients with secondary interstitial lung disease (ILD). Both, the number of inspiratory crackles and coughs showed significant correlations with the severity of dyspnoea and ILD-pattern. Wheezing occurred in 15 patients, with a median of 25.7 wheezes/h.
Discussion
Overnight long-term auscultation in patients with pulmonary fibrosis proved feasible in our study. Regardless of the aetiology and disease severity, crackles were detected in the recordings of all fibrosis patients, but not cough. Wheezing occurred in 15 out of 16 patients, the significance of which for clinical practice must still remain unclear.
Publisher
Research Square Platform LLC
Reference36 articles.
1. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001;American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias;Am J Respir Crit Care Med,2002
2. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias;Travis WD;Am J Respir Crit Care Med,2013
3. Idiopathic Pulmonary Fibrosis;Lederer DJ;N Engl J Med,2018
4. Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis;Kreuter M;Am J Respir Crit Care Med,2021
5. S2K-Leitlinie zur Diagnostik der idiopathischen Lungenfibrose;Behr J;Pneumologie,2020
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献